Cancer cells typically have a higher metabolic rate compared to normal cells, leading to increased uptake of FDG. FDG-PET scans can identify these areas of high metabolic activity, helping to detect cancer, evaluate the extent of the disease, and monitor the effectiveness of treatment.
